| Code | 06215 | ||||||||||
| MA number | 56/0069/01-S | ||||||||||
| Product Form: | plu igf 1x11,25 mg+1x2 ml disp.prostr. (liek.inj.+amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Ipsen Pharma, France | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | vial | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 06.02.2001 |
| PIL: |
PIL Diphereline SR 11.25 mg_2 needles_05_2023.pdf
|
| PIL: |
PIL_Diphereline SR 11.25 mg_3 needles_05_2023.pdf
|
| SPC: |
SPC_Diphereline SR 11.25 mg_3 needles_05_2023.pdf
|
| SPC: |
SPC Diphereline SR 11.25 mg_2 needles_05_2023.pdf
|
| Safety feature | Yes |
| Data update: | 27.09.2019 |
